These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9257832

  • 1. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 4. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C, Coulon F, Haspot F, Mérieau E, Renaudin K, Martinet B, Vanhove B.
    Xenotransplantation; 2007 Jan 27; 14(1):25-33. PubMed ID: 17214702
    [Abstract] [Full Text] [Related]

  • 5. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403
    [Abstract] [Full Text] [Related]

  • 6. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA.
    J Immunol; 1999 Jun 01; 162(11):6368-77. PubMed ID: 10352249
    [Abstract] [Full Text] [Related]

  • 7. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 01; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 8. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
    Tikkanen JM, Lemström KB, Koskinen PK.
    Am J Respir Crit Care Med; 2002 Mar 01; 165(5):724-9. PubMed ID: 11874822
    [Abstract] [Full Text] [Related]

  • 9. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA.
    J Immunol; 1999 Feb 15; 162(4):1947-51. PubMed ID: 9973463
    [Abstract] [Full Text] [Related]

  • 10. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA, Furukawa Y, McAdam AJ, Alexander SI, Libby P, Mitchell RN, Sharpe AH.
    J Immunol; 1999 Oct 01; 163(7):3753-7. PubMed ID: 10490971
    [Abstract] [Full Text] [Related]

  • 11. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA.
    J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Immunol; 2003 May 01; 12(1):41-8. PubMed ID: 14551031
    [Abstract] [Full Text] [Related]

  • 13. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB.
    J Immunol; 1999 Apr 15; 162(8):4983-90. PubMed ID: 10202046
    [Abstract] [Full Text] [Related]

  • 14. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
    Baliga P, Chavin KD, Qin L, Woodward J, Lin J, Linsley PS, Bromberg JS.
    Transplantation; 1994 Nov 27; 58(10):1082-90. PubMed ID: 7526493
    [Abstract] [Full Text] [Related]

  • 15. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 16. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 17. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
    Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH.
    J Clin Invest; 1998 Jun 01; 101(11):2309-18. PubMed ID: 9616202
    [Abstract] [Full Text] [Related]

  • 18. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
    Yang Z, Rostami S, Koeberlein B, Barker CF, Naji A.
    Transplantation; 1999 Jun 27; 67(12):1517-23. PubMed ID: 10401757
    [Abstract] [Full Text] [Related]

  • 19. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH.
    J Clin Invest; 1996 Feb 01; 97(3):833-8. PubMed ID: 8609241
    [Abstract] [Full Text] [Related]

  • 20. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.